Home / Inspections / 786188

FDA Inspection 786188 — Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals Inc — FEI 1000514603

The FDA completed an inspection of Regeneron Pharmaceuticals Inc on June 8, 2012 in Rensselaer, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 8, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rensselaer, NY (United States)

Facility

Other inspections at this facility

  • 1230565 (VAI Fri Mar 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1155063 (VAI Mon Oct 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1106821 (VAI Fri Oct 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1030807 (NAI Thu Oct 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 983604 (VAI Fri Aug 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources